Monday 3rd August 2009 - Australia’s national body for the biotechnology and life sciences industry, AusBiotech, has announced AusBiotech 2009 - the premier Australasian biotechnology conference. The conference is expected to attract more than 1,400 delegates, including a large number of international delegates.
Australia’s biotechnology sector has matured into an internationally recognised industry, ranking sixth in the world in innovative biotechnologies. AusBiotech 2009 will bring together the who’s who of biotechnology from Australia and around the world in one world-class event.
AusBiotech 2009 will be preceded by the inaugural AusBiotech Australasian Life Sciences Investment Summit, an invitation-only, one-day event designed specifically to demonstrate to investors the high calibre of investment potential in Australia’s biotechnology industry.
EVENT DETAILS
When: Tuesday 27 October - Australasian Life Sciences Investment Summit And Wednesday 28 – Friday 30 October – AusBiotech 2009
Where: Melbourne Convention and Exhibition Centre, Clarendon Street, Melbourne
The Conference features a comprehensive program that includes sessions on four biotechnology streams: human health; medical technology; agriculture, industrial and food; and investment and business. Following the success of last year’s conference the event will again feature:
• Satellite Events;
• BioIndustry Exhibition; and
• Business Matching Program, giving delegates access to the bio-partnering system to plan meetings with other delegates - last year resulting in 2608 meeting requests and 1226 confirmed meetings.
The conference presentations cover a range of topics including: Biopharmaceuticals in a Post-GFC World; Global Regulatory Challenges and Opportunities; Product Development and Regulatory Aspects in Asia Pacific; and Changing Business Models and New Financial Opportunities and Health Technologies.
KEY SPEAKERS
• Professor David de Kretser, Governor of Victoria
• Mr Alan Oster, Group Chief Economist, National Australia Bank
• Dr Victoria Elegant, Vice-President, Asia-Pacific, Regulatory Affairs/Pharmacovigilance, Baxter Healthcare Corporation
• Dr Megan Clark, Chief Executive, CSIRO Australia
• Dr Johnsee Lee, President, Industrial Technology Research Institute, Taiwan
• Dr Ganesh Kishore, CEO Malaysian Life Sciences Fund, Burrill & Company / Malaysian Technology Development Corporation, United States
About AusBiotech
AusBiotech is Australia’s voice on biotechnology, and represents more than 3,000 members, encompassing medicines, medical diagnostics and devices, agriculture, alternative fuels and climate change.
